OpenURL Connection Search

Select item for more details and to access through your institution.

Reply to Farina ti et al.: classification of‘intermediate stage’, untreated hepatocellular carcinoma patients: the neighbour's grass is not so green.
Published in:
2004
By:
- Giannini, E. G.;
- Testa, R.
Publication type:
Letter
Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension.
Published in:
Journal of Internal Medicine, 2009, v. 266, n. 6, p. 537, doi. 10.1111/j.1365-2796.2009.02130.x
By:
- Giannini, E. G.;
- Basso, M.;
- Savarino, V.;
- Picciotto, A.
Publication type:
Article
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.
Published in:
2015
By:
- Biselli, M;
- Conti, F;
- Gramenzi, A;
- Frigerio, M;
- Cucchetti, A;
- Fatti, G;
- D'Angelo, M;
- Dall'Agata, M;
- Giannini, E G;
- Farinati, F;
- Ciccarese, F;
- Andreone, P;
- Bernardi, M;
- Trevisani, F
Publication type:
journal article
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis.
Published in:
British Journal of Cancer, 2015, v. 112, n. 1, p. 69, doi. 10.1038/bjc.2014.536
By:
- Biselli, M;
- Conti, F;
- Gramenzi, A;
- Frigerio, M;
- Cucchetti, A;
- Fatti, G;
- D'Angelo, M;
- Dall'Agata, M;
- Giannini, E G;
- Farinati, F;
- Ciccarese, F;
- Andreone, P;
- Bernardi, M;
- Trevisani, F
Publication type:
Article
Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
Published in:
Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 8, p. 1055, doi. 10.1111/j.1365-2036.2006.02889.x
By:
- GIANNINI, E. G.
Publication type:
Article
A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication.
Published in:
Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 2, p. 281, doi. 10.1111/j.1365-2036.2006.02756.x
By:
- GIANNINI, E. G.;
- BILARDI, C.;
- DULBECCO, P.;
- MAMONE, M.;
- SANTI, M. L.;
- TESTA, R.;
- MANSI, C.;
- SAVARINO, V.
Publication type:
Article
Letter to the Editor Non-invasive assessment of liver function: trying not to miss an opportunity.
Published in:
2004
By:
- Giannini, E. G.;
- Testa, R.
Publication type:
Letter
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn.
Published in:
2018
By:
- Marabotto, E.;
- Furnari, M.;
- Giannini, E. G.;
- Savarino, V.;
- Savarino, E.
Publication type:
Letter to the Editor
Editorial: a step forward in refining prognostication for patients with HIV-associated hepatocellular carcinoma.
Published in:
2018
By:
- Giannini, E. G.
Publication type:
Editorial
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 160, doi. 10.1111/apt.13821
By:
- Petta, S.;
- Cabibbo, G.;
- Barbara, M.;
- Attardo, S.;
- Bucci, L.;
- Farinati, F.;
- Giannini, E. G.;
- Tovoli, F.;
- Ciccarese, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Virdone, R.;
- Marra, F.;
- Felder, M.;
- Morisco, F.;
- Benvegnù, L.
Publication type:
Article
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 11, p. 1240, doi. 10.1111/apt.13581
By:
- Furnari, M.;
- Bodini, G.;
- Giannini, E. G.;
- Savarino, V.
Publication type:
Article
Years of life that could be saved from prevention of hepatocellular carcinoma.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 7, p. 814, doi. 10.1111/apt.13554
By:
- Cucchetti, A.;
- Trevisani, F.;
- Bucci, L.;
- Ravaioli, M.;
- Farinati, F.;
- Giannini, E. G.;
- Ciccarese, F.;
- Piscaglia, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Maida, M.;
- Felder, M.;
- Morisco, F.;
- Gasbarrini, A.;
- Gemini, S.;
- Foschi, F. G.
Publication type:
Article
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 3, p. 385, doi. 10.1111/apt.13485
By:
- Bucci, L.;
- Garuti, F.;
- Camelli, V.;
- Lenzi, B.;
- Farinati, F.;
- Giannini, E. G.;
- Ciccarese, F.;
- Piscaglia, F.;
- Rapaccini, G. L.;
- Di Marco, M.;
- Caturelli, E.;
- Zoli, M.;
- Borzio, F.;
- Sacco, R.;
- Maida, M.;
- Felder, M.;
- Morisco, F.;
- Gasbarrini, A.;
- Gemini, S.;
- Foschi, F. G.
Publication type:
Article
IL28B rs12979860 C/T polymorphism in elderly chronic hepatitis C patients treated with pegylated-interferon and ribavirin.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 398, doi. 10.1111/j.1365-2036.2011.04734.x
By:
- Giannini, E. G.;
- Marenco, S.;
- Baldissarro, I.;
- Fazio, V.
Publication type:
Article
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 8, p. 1000, doi. 10.1111/j.1365-2036.2010.04436.x
By:
- Furnari, M.;
- Parodi, A.;
- Gemignani, L.;
- Giannini, E. G.;
- Marenco, S.;
- Savarino, E.;
- Assandri, L.;
- Fazio, V.;
- Bonfanti, D.;
- Inferrera, S.;
- Savarino, V.
Publication type:
Article
Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 4, p. 493, doi. 10.1111/j.1365-2036.2009.04198.x
By:
- GIANNINI, E. G.;
- BODINI, G.;
- CORBO, M.;
- SAVARINO, V.;
- RISSO, D.;
- DI NOLFO, M. A.;
- DEL POGGIO, P.;
- BENVEGNÙ, L.;
- FARINATI, F.;
- ZOLI, M.;
- BORZIO, F.;
- CATURELLI, E.;
- CHIARAMONTE, M.;
- TREVISANI, F.
Publication type:
Article
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 4, p. 502, doi. 10.1111/j.1365-2036.2009.04201.x
By:
- GIANNINI, E. G.;
- BASSO, M.;
- SAVARINO, V.;
- PICCIOTTO, A.
Publication type:
Article
Hepatobiliary and Pancreatic: A rare cause of portal hypertension.
Published in:
Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 1, p. 11, doi. 10.1111/jgh.13038
By:
- Plaz Torres, M C;
- Romana, C.;
- Coppo, C;
- Zentilin, P;
- Grillo, F;
- Savarino, V;
- Giannini, E G
Publication type:
Article
Epidemiology of thrombocytopenia in patients with chronic hepatitis C: more than meets the eye.
Published in:
Journal of Viral Hepatitis, 2011, v. 18, n. 1, p. 8, doi. 10.1111/j.1365-2893.2010.01368.x
By:
- Giannini, E. G.;
- Savarino, V.
Publication type:
Article
Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants’ serum levels in anti-HCV positive cirrhotic patients.
Published in:
Journal of Viral Hepatitis, 2010, v. 17, n. 8, p. 563, doi. 10.1111/j.1365-2893.2009.01217.x
By:
- Giannini, E. G.;
- Basso, M.;
- Bazzica, M.;
- Contini, P.;
- Marenco, S.;
- Savarino, V.;
- Picciotto, A.
Publication type:
Article

Found: 20